These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32310188)

  • 1. Detecting the Cognitive Prodrome of Dementia in Parkinson's Disease.
    De Roy J; Postuma RB; Brillon-Corbeil M; Montplaisir J; Génier Marchand D; Escudier F; Panisset M; Chouinard S; Gagnon JF
    J Parkinsons Dis; 2020; 10(3):1033-1046. PubMed ID: 32310188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder.
    Génier Marchand D; Postuma RB; Escudier F; De Roy J; Pelletier A; Montplaisir J; Gagnon JF
    Ann Neurol; 2018 May; 83(5):1016-1026. PubMed ID: 29665124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Development of the Social Functioning Scale for Patients with Parkinson's Disease.
    Su FT; Tai CH; Tan CH; Hwang WJ; Yu RL
    J Parkinsons Dis; 2020; 10(3):1143-1151. PubMed ID: 32444559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: A Prospective Study of REM Sleep Behavior Disorder.
    Génier Marchand D; Montplaisir J; Postuma RB; Rahayel S; Gagnon JF
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study.
    Sanyal J; Banerjee TK; Rao VR
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):630-6. PubMed ID: 24771763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
    Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
    J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
    Sousa NMF; Brucki SMD
    Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
    Martinez-Horta S; Horta-Barba A; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Garcia-Ruiz P; Júlio F; Januário C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Neurol; 2020 May; 267(5):1527-1535. PubMed ID: 32030521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometrics and diagnostics of the Italian version of the Alternate Verbal Fluency Battery (AVFB) in non-demented Parkinson's disease patients.
    Aiello EN; Mameli F; Ruggiero F; Zirone E; Zago S; Piacentini S; Poletti B; Reitano MR; Santangelo G; Ticozzi N; Silani V; Priori A; Ferrucci R
    Neurol Sci; 2024 Aug; 45(8):3767-3774. PubMed ID: 38467953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.
    Latreille V; Carrier J; Gaudet-Fex B; Rodrigues-Brazète J; Panisset M; Chouinard S; Postuma RB; Gagnon JF
    Brain; 2016 Apr; 139(Pt 4):1189-99. PubMed ID: 26912643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
    Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
    Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.